• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Stenosis (2263)
Event Date 01/11/2020
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was received through literature ¿mid-term results of in situ fenestration stented with balloon-expandable bare metal stents during thoracic endovascular aortic repair¿ published by catheter cardiovasc interv.2020; 95:1163¿1168.The study was to assess the safety, feasibility and effectiveness of balloon-expandable bare metal stents (bms) as bridge stents during thoracic endovascular aortic repair (tevar).The results state in the series, one case with an 8*50 mm viabahn®-covered stent had a 50% residual stenosis in the connecting part of aortic graft and bridging stent after pre-dilation.The stenosis was not resolved after several dilations, but it was resolved after another 8*37-mm balloon-expandable bare stent was inserted.
 
Manufacturer Narrative
Remove c1.H6: 213-due to an unknown lot/serial number and no device return, an investigation could not be performed.Citation: jun bai, yandong liu, jie jin, jianjin wu.Mid-term results of in situ fenestration stented with balloon-expandable bare metal stents during thoracic endovascular aortic repair.Catheter cardiovasc interv.2020; 95:1163¿1168.Doi: 10.1002/ccd.28743.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
pixie xi
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14882109
MDR Text Key295116336
Report Number2017233-2022-03086
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
-
-